INDY as a Therapeutic Target for Cardio-Metabolic Disease
Open Access
- 14 March 2022
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 12 (3) , 244
Abstract
Decreased expression of the plasma membrane citrate transporter INDY (acronym I’m Not Dead, Yet) promotes longevity and protects from high-fat diet- and aging-induced metabolic derangements. Preventing citrate import into hepatocytes by different strategies can reduce hepatic triglyceride accumulation and improve hepatic insulin sensitivity, even in the absence of effects on body composition. These beneficial effects likely derive from decreased hepatic de novo fatty acid biosynthesis as a result of reduced cytoplasmic citrate levels. While in vivo and in vitro studies show that inhibition of INDY prevents intracellular lipid accumulation, body weight is not affected by organ-specific INDY inhibition. Besides these beneficial metabolic effects, INDY inhibition may also improve blood pressure control through sympathetic nervous system inhibition, partly via reduced peripheral catecholamine synthesis. These effects make INDY a promising candidate with bidirectional benefits for improving both metabolic disease and blood pressure control.Keywords
This publication has 61 references indexed in Scilit:
- Elevated citrate levels in non‐alcoholic fatty liver disease: The potential of citrate to promote radical productionFEBS Letters, 2013
- Lithium toxicity profile: a systematic review and meta-analysisThe Lancet, 2012
- Deletion of the Mammalian INDY Homolog Mimics Aspects of Dietary Restriction and Protects against Adiposity and Insulin Resistance in MiceCell Metabolism, 2011
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese SubjectsNew England Journal of Medicine, 2010
- Long-lived Indy and calorie restriction interact to extend life spanProceedings of the National Academy of Sciences, 2009
- Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice #Hepatology, 2009
- Diabetic Hypertensive Leptin Receptor–Deficient db/db Mice Develop Cardioregulatory Autonomic DysfunctionHypertension, 2009
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Human sodium-coupled citrate transporter, the orthologue of Drosophila Indy, as a novel target for lithium actionBiochemical Journal, 2003
- Isolated Failure of Autonomic Noradrenergic NeurotransmissionNew England Journal of Medicine, 1986